CEO
Julie Kim to Succeed Christophe Weber as Takeda’s CEO in 2026
Takeda, Julie Kim, Christophe Weber, CEO succession, pharmaceutical industry, leadership transition, biopharmaceutical company
GSK Advances Liver Disease Research and Biotech CEO Sisterhood Grows Influence
GSK, liver disease, Biotech CEO Sisterhood, JPM25, pharmaceutical industry, women in biotech
Jazz Pharmaceuticals Announces CEO Succession Plan as Co-Founder Bruce Cozadd Prepares to Retire
Jazz Pharmaceuticals, Bruce Cozadd, CEO succession plan, retirement, biopharmaceutical company, leadership transition
Avalere Health Appoints Amar Urhekar as New CEO to Drive Strategic Growth
Amar Urhekar, Avalere Health, CEO appointment, healthcare strategic partner, leadership transition
Pleno Secures $25M Funding for Commercial Launch, Appoints New CEO from Illumina
Pleno, multiomics, funding, commercial launch, new CEO, Illumina
UnitedHealthcare CEO Brian Thompson Fatally Shot in Targeted Attack Outside New York City Hotel
UnitedHealthcare, CEO Brian Thompson, targeted killing, New York City, hotel shooting, investor meeting
Sonata Therapeutics Undergoes Restructuring: CEO Exits, 20 Staff Members Laid Off
Sonata Therapeutics, Flagship Pioneering, CEO departure, staff layoffs, biotech restructuring
Bayer’s Q3 Earnings Plummet 37%, CEO Urges Patience Amid Performance-Boosting Strategy
Bayer, Q3 earnings, decline, CEO Bill Anderson, performance-boosting strategy, pharmaceuticals, crop science, generics, Xarelto, Nubeqa, Kerendia.
Insights from Jade CEO: Reverse Merger and IgAN Drug Development
Jade CEO, Reverse Merger, IgAN Drugs, Pharmaceutical Development, Biotech Mergers
Masimo Appoints Michelle Brennan as Interim CEO Following Joe Kiani’s Resignation
Masimo, Joe Kiani, Michelle Brennan, Politan Capital Management, Interim CEO, Board of Directors, Resignation